Ameriprise’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $133K | Buy |
16,331
+65
| +0.4% | +$589 | ﹤0.01% | 3935 |
|
|
2025
Q4 | $109K | Sell |
16,266
-2,819
| -15% | -$21.3K | ﹤0.01% | 3998 |
|
|
2025
Q3 | $165K | Sell |
19,085
-5
| -0% | -$39 | ﹤0.01% | 3926 |
|
|
2025
Q2 | $120K | Sell |
19,090
-12,656
| -40% | -$83.8K | ﹤0.01% | 3871 |
|
|
2025
Q1 | $203K | Sell |
31,746
-1,310
| -4% | -$10.8K | ﹤0.01% | 3793 |
|
|
2024
Q4 | $266K | Buy |
33,056
+16,299
| +97% | +$157K | ﹤0.01% | 3770 |
|
|
2024
Q3 | $212K | Sell |
16,757
-12,017
| -42% | -$155K | ﹤0.01% | 3735 |
|
|
2024
Q2 | $364K | Sell |
28,774
-3,365
| -10% | -$33.9K | ﹤0.01% | 3536 |
|
|
2024
Q1 | $154K | Buy |
+32,139
| New | +$149K | ﹤0.01% | 3723 |
|
|
2023
Q4 | – | Sell |
-31,386
| Closed | -$227K | – | 3955 |
|
|
2023
Q3 | $227K | Sell |
31,386
-50,470
| -62% | -$403K | ﹤0.01% | 3662 |
|
|
2023
Q2 | $608K | Buy |
+81,856
| New | +$644K | ﹤0.01% | 3362 |
|
|
2023
Q1 | – | Sell |
-28,924
| Closed | -$297K | – | 4011 |
|
|
2022
Q4 | $297K | Buy |
+28,924
| New | +$510K | ﹤0.01% | 3587 |
|
|
2022
Q3 | – | Sell |
-239,251
| Closed | -$12.3M | – | 4007 |
|
|
2022
Q2 | $12.3M | Buy |
239,251
+199,244
| +498% | +$10.3M | ﹤0.01% | 1566 |
|
|
2022
Q1 | $2.94M | Sell |
40,007
-258,309
| -87% | -$23M | ﹤0.01% | 2738 |
|
|
2021
Q4 | $42.5M | Buy |
298,316
+194,376
| +187% | +$33.4M | 0.01% | 924 |
|
|
2021
Q3 | $21.5M | Sell |
103,940
-534,148
| -84% | -$118M | 0.01% | 1209 |
|
|
2021
Q2 | $135M | Buy |
638,088
+38,678
| +6% | +$7.09M | 0.04% | 434 |
|
|
2021
Q1 | $109M | Sell |
599,410
-268,150
| -31% | -$53.4M | 0.04% | 471 |
|
|
2020
Q4 | $96.7M | Buy |
867,560
+253,193
| +41% | +$26.9M | 0.03% | 487 |
|
|
2020
Q3 | $66.6M | Buy |
614,367
+565,600
| +1,160% | +$68.9M | 0.03% | 543 |
|
|
2020
Q2 | $4.07M | Buy |
48,767
+35,644
| +272% | +$1.36M | ﹤0.01% | 2209 |
|
|
2020
Q1 | $178K | Buy |
+13,123
| New | +$111K | ﹤0.01% | 3457 |
|
|
2019
Q2 | – | Sell |
-799
| Closed | -$9K | – | 3762 |
|
|
2019
Q1 | $9K | Sell |
799
-51,752
| -98% | -$1.63M | ﹤0.01% | 3681 |
|
|
2018
Q4 | $1.93M | Sell |
52,551
-50,938
| -49% | -$1.97M | ﹤0.01% | 2660 |
|
|
2018
Q3 | $3.89M | Sell |
103,489
-3,880
| -4% | -$109K | ﹤0.01% | 2503 |
|
|
2018
Q2 | $2.88M | Buy |
107,369
+90
| +0.1% | +$3.04K | ﹤0.01% | 2570 |
|
|
2018
Q1 | $4.51M | Sell |
107,279
-51,512
| -32% | -$2.07M | ﹤0.01% | 2250 |
|
|
2017
Q4 | $3.94M | Buy |
158,791
+21,029
| +15% | +$513K | ﹤0.01% | 2294 |
|
|
2017
Q3 | $3.14M | Buy |
137,762
+21,863
| +19% | +$489K | ﹤0.01% | 2385 |
|
|
2017
Q2 | $2.67M | Buy |
115,899
+27,363
| +31% | +$537K | ﹤0.01% | 2464 |
|
|
2017
Q1 | $2.27M | Buy |
+88,536
| New | +$2.43M | ﹤0.01% | 2524 |
|
|
2016
Q4 | – | Sell |
-3,795
| Closed | -$159K | – | 3926 |
|
|
2016
Q3 | $159K | Sell |
3,795
-193,803
| -98% | -$25M | ﹤0.01% | 3604 |
|
|
2016
Q2 | $28.7M | Sell |
197,598
-25,113
| -11% | -$2.88M | 0.02% | 724 |
|
|
2016
Q1 | $23M | Buy |
222,711
+56,103
| +34% | +$6.02M | 0.01% | 833 |
|
|
2015
Q4 | $28M | Buy |
166,608
+12,994
| +8% | +$2M | 0.02% | 739 |
|
|
2015
Q3 | $21.7M | Sell |
153,614
-19,123
| -11% | -$4.29M | 0.01% | 885 |
|
|
2015
Q2 | $38.5M | Buy |
172,737
+122,728
| +245% | +$21.6M | 0.02% | 628 |
|
|
2015
Q1 | $8.27M | Sell |
50,009
-11,713
| -19% | -$1.9M | ﹤0.01% | 1714 |
|
|
2014
Q4 | $7.32M | Sell |
61,722
-17,524
| -22% | -$1.83M | ﹤0.01% | 1773 |
|
|
2014
Q3 | $6.61M | Sell |
79,246
-10,197
| -11% | -$922K | ﹤0.01% | 1824 |
|
|
2014
Q2 | $8.27M | Sell |
89,443
-2,252
| -2% | -$198K | ﹤0.01% | 1702 |
|
|
2014
Q1 | $8.31M | Buy |
91,695
+25,335
| +38% | +$2.83M | 0.01% | 1659 |
|
|
2013
Q4 | $6.8M | Buy |
66,360
+65,938
| +15,625% | +$4.66M | ﹤0.01% | 1788 |
|
|
2013
Q3 | $27K | Hold |
422
| – | – | ﹤0.01% | 4204 |
|
|
2013
Q2 | $17K | Buy |
+422
| New | +$18.3K | ﹤0.01% | 4394 |
|
Other funds holding NVAX
SCM
VPM
VCM
S
Ameriprise's NVAX Position: Q1 2026 in Review
Ameriprise increased its Novavax (NVAX) stake by 0.4% in Q1 2026, buying an estimated $589 and bringing the position to 16,331 shares worth $133K. The position accounts for ﹤0.01% of the portfolio, ranked #3935.
Ameriprise first reported a position in NVAX in Q2 2013 and has held it in 45 quarters since. The position peaked at $135M in Q2 2021. 257 funds tracked by Wall St. Rank hold NVAX as of Q1 2026.
- Ameriprise held 16,331 shares of Novavax worth $133K as of Q1 2026.
- Ameriprise bought 65 Novavax shares in Q1 2026, an estimated $589.
- Novavax made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #3935 holding.
- Ameriprise first reported a position in Novavax in Q2 2013 and has held it in 45 quarters since.
- Ameriprise's Novavax position peaked at $135M in Q2 2021.
- 257 funds tracked by Wall St. Rank held Novavax as of Q1 2026.
Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.